Philogen S.p.A. (PHIL.MI)

EUR 21.7

(-0.46%)

EBITDA Summary of Philogen S.p.A.

Philogen S.p.A.'s latest annual EBITDA in 2023 was -2.04 Million EUR , down -396.01% from previous year.
Philogen S.p.A.'s latest quarterly EBITDA in 2023 FY was N/A , down -396.01% from previous quarter.
Philogen S.p.A. reported an annual EBITDA of -1.18 Million EUR in 2022, up 116.39% from previous year.
Philogen S.p.A. reported an annual EBITDA of -12.97 Million EUR in 2021, down -38.16% from previous year.
Philogen S.p.A. reported a quarterly EBITDA of -7.28 Million EUR for 2023 Q3, down -283.03% from previous quarter.
Philogen S.p.A. reported a quarterly EBITDA of 3.97 Million EUR for 2023 Q1, up 217.77% from previous quarter.

Annual EBITDA Chart of Philogen S.p.A. (2023 - 2017)

Historical Annual EBITDA of Philogen S.p.A. (2023 - 2017)

Year	EBITDA	EBITDA Growth
2023	-2.04 Million EUR	-396.01%
2022	-1.18 Million EUR	116.39%
2021	-12.97 Million EUR	-38.16%
2020	-10.53 Million EUR	-228.15%
2019	3.82 Million EUR	-317.58%
2018	2.88 Million EUR	320.23%
2017	4.95 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	3.97 Million EUR	0.0%
2023 Q3	-7.28 Million EUR	-283.03%
2023 Q1	3.97 Million EUR	217.77%
2023 FY	- EUR	-396.01%
2023 Q4	-7.28 Million EUR	0.0%
2022 Q4	-3.37 Million EUR	0.0%
2022 FY	- EUR	116.39%
2022 Q3	-3.37 Million EUR	-148.6%
2022 Q2	6.95 Million EUR	63.77%
2022 Q1	4.24 Million EUR	147.86%
2021 Q1	-4.25 Million EUR	-124.68%
2021 FY	- EUR	-38.16%
2021 Q4	-8.87 Million EUR	-145.91%
2021 Q3	-3.6 Million EUR	50.66%
2021 Q2	-7.31 Million EUR	-71.98%
2020 Q1	-3.02 Million EUR	-13232.61%
2020 FY	- EUR	-228.15%
2020 Q4	-1.89 Million EUR	0.0%
2020 Q2	-3.02 Million EUR	0.0%
2019 Q4	23 Thousand EUR	0.0%
2019 FY	- EUR	-317.58%
2018 FY	- EUR	320.23%
2017 FY	- EUR	0.0%

Peer EBITDA Comparison of Philogen S.p.A.

Name	EBITDA	EBITDA Difference
ARTERRA BIOSCIENCE	1.59 Million EUR	228.625%
Ulisse Biomed S.p.A.	-2.14 Million EUR	4.452%